The leukotriene receptor antagonist montelukast in the treatment of non-alcoholic steatohepatitis: a proof-of-concept, randomized, double-blind, placebo-controlled trial - Abdallah, M S; Eldeen, A H; Tantawy, S S (Eur J Pharmacol, 2021)